Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 2 3Phase NA 1Phase 4 1

Status

Completed 26Unknown 9Terminated 5Active not recruiting 5Recruiting 3Withdrawn 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vulvar Neoplasms 1Seminoma 1Gynecological Cancers 1

Interventions

pembrolizumab 223Carboplatin 222Specimen Handling 194Cisplatin 192Magnetic Resonance Spectroscopy 165Radiotherapy 153Bevacizumab 143Gemcitabine 136Cyclophosphamide 135Drug Therapy 119Capecitabine 118Paclitaxel 116Oxaliplatin 111Nivolumab 105Biopsy 104venetoclax 103tislelizumab 83Rituximab 83durvalumab 82toripalimab 78Fluorouracil 73Etoposide 72Docetaxel 69Dexamethasone 69sintilimab 67Pemetrexed 67atezolizumab 65Radiosurgery 65Azacitidine 63130-nm albumin-bound paclitaxel 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Bleomycin × Clear all
NCT06144736 2025-09-15

PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND

Heinrich-Heine University, Duesseldorf

Phase 2 Recruiting
60 enrolled

Seminoma

NCT04760327 2024-10-17

GynECT

Institute of Oncology Ljubljana

Phase 2 Recruiting
30 enrolled

Gynecological Cancers

NCT05395962 2022-05-27

Elechtra

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase 2 Recruiting
92 enrolled
Gynecologic

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡